For: | Maiolino G, Bisogni V, Rossitto G, Rossi GP. Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications. World J Cardiol 2015; 7(10): 609-620 [PMID: 26516415 DOI: 10.4330/wjc.v7.i10.609] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v7/i10/609.htm |
Number | Citing Articles |
1 |
L. N. Solovyeva. Laboratory tests and biopsychosocial approach in the examination of patients with brachiocephalic arteries atherosclerosis. Regional blood circulation and microcirculation 2017; 16(2): 4 doi: 10.24884/1682-6655-2017-16-2-4-16
|
2 |
Minjoo Kim, Minkyung Kim, Hye Jin Yoo, Hye Young Jang, Sang-Hyun Lee, Jong Ho Lee, Alberto G Passi. Effects of overweight and the PLA2G7 V279F polymorphism on the association of age with systolic blood pressure. PLOS ONE 2017; 12(3): e0173611 doi: 10.1371/journal.pone.0173611
|
3 |
Chenyu Xu, Fenfang Yu, Shan Mao, Ying Shi, Qian Li, Surong Fang, Yan Tan, Wei Gu, Liang Ye. Lipoprotein-associated phospholipase A2 predicted cardiovascular disease in obstructive sleep apnea syndrome. Respiratory Medicine 2020; 163: 105881 doi: 10.1016/j.rmed.2020.105881
|
4 |
Minjie Yuan, Linjuan Feng, Dongqi Zhao, Dongdong Shi, Hui Wang, Junbo Wei, Man Wang. Diagnostic Utility of Combining Homocysteine, Lipoprotein-Associated Phospholipase A2, and the C-Reactive Protein-to-Albumin Ratio for Assessing Carotid Atherosclerosis and Plaque Stability in Patients with Essential Hypertension. Cardiovascular Toxicology 2025; 25(1): 24 doi: 10.1007/s12012-024-09939-1
|
5 |
Andreana De Mauri, Matteo Vidali, Doriana Chiarinotti, Giorgio Bellomo, Roberta Rolla. Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients. Journal of Nephrology 2019; 32(2): 283 doi: 10.1007/s40620-018-0521-3
|
6 |
Xiyi Huang, Shaomin Yang, Qiang Zhao, Xinjie Chen, Jialing Pan, Shaofen Lai, Fusheng Ouyang, Lingda Deng, Yongxing Du, Xiaohong Li, Qiugen Hu, Baoliang Guo, Jiemei Liu. Predictive Value of Non-high-Density Lipoprotein Cholesterol and Neutrophil-Lymphocyte Ratio for Coronary Artery Vulnerable Plaques in Type 2 Diabetes Mellitus. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.927768
|
7 |
Juana Virginia Tapia-Vieyra, Blanca Delgado-Coello, Jaime Mas-Oliva. Atherosclerosis and Cancer; A Resemblance with Far-reaching Implications. Archives of Medical Research 2017; 48(1): 12 doi: 10.1016/j.arcmed.2017.03.005
|
8 |
Tanvi Pingle, Girdhari Lal Gupta. Phospholipases in Physiology and Pathology. 2023; : 203 doi: 10.1016/B978-0-443-21800-2.00019-1
|
9 |
Yuping Yang, Tao Xue, Juehua Zhu, Jiayi Xu, Xiaowei Hu, Penghao Wang, Tao Kong, Yan Yan, Lihui Yang, Shouru Xue. Serum lipoprotein-associated phospholipase A2 predicts the formation of carotid artery plaque and its vulnerability in anterior circulation cerebral infarction. Clinical Neurology and Neurosurgery 2017; 160: 40 doi: 10.1016/j.clineuro.2017.06.007
|
10 |
Weronika Bargieł, Katarzyna Cierpiszewska, Klara Maruszczak, Anna Pakuła, Dominika Szwankowska, Aleksandra Wrzesińska, Łukasz Gutowski, Dorota Formanowicz. Recognized and Potentially New Biomarkers—Their Role in Diagnosis and Prognosis of Cardiovascular Disease. Medicina 2021; 57(7): 701 doi: 10.3390/medicina57070701
|
11 |
Kazuhiko Kotani. Plasma Lipoprotein-Associated Phospholipase A2 Levels Correlated with the Cardio-Ankle Vascular Index in Long-Term Type 2 Diabetes Mellitus Patients. International Journal of Molecular Sciences 2016; 17(5): 634 doi: 10.3390/ijms17050634
|
12 |
Andreana De Mauri, Matteo Vidali, Doriana Chiarinotti, Umberto Dianzani, Roberta Rolla. Lipoprotein‐associated phospholipase A2 predicts lower limb ischemia in hemodialysis subjects. Therapeutic Apheresis and Dialysis 2020; 24(5): 548 doi: 10.1111/1744-9987.13465
|
13 |
Francesca Spadaro, Serena Cecchetti, Laura Fantuzzi. Macrophages and Phospholipases at the Intersection between Inflammation and the Pathogenesis of HIV-1 Infection. International Journal of Molecular Sciences 2017; 18(7): 1390 doi: 10.3390/ijms18071390
|
14 |
Wirdatun Nafisah, Annia Zhafarina Dalilati, Yuyun Ika Christina, Mochammad Fitri Atho’illah, Muhaimin Rifa’i, Tengku Natasha Eleena Tengku Ahmad Noor, Alexander Patera Nugraha. Amstirdam coffee ameliorates Lp-PLA2 and the inflammatory response in an atherosclerosis mice. Pharmacia 2024; 71: 1 doi: 10.3897/pharmacia.71.e106817
|
15 |
So-Ra Kim, Jong-Ik Heo, Jeong-Woo Park, Chang-Mo Kang, Kwang Seok Kim. Radiation-induced lipoprotein-associated phospholipase A2 increases lysophosphatidylcholine and induces endothelial cell damage. Toxicology 2021; 458: 152841 doi: 10.1016/j.tox.2021.152841
|
16 |
Cristina Andreea Adam, Delia Lidia Șalaru, Cristina Prisacariu, Dragoș Traian Marius Marcu, Radu Andy Sascău, Cristian Stătescu. Novel Biomarkers of Atherosclerotic Vascular Disease—Latest Insights in the Research Field. International Journal of Molecular Sciences 2022; 23(9): 4998 doi: 10.3390/ijms23094998
|
17 |
Björn Fagerberg, Yan Borné, Lars Barregard, Gerd Sallsten, Niklas Forsgard, Bo Hedblad, Margaretha Persson, Gunnar Engström. Cadmium exposure is associated with soluble urokinase plasminogen activator receptor, a circulating marker of inflammation and future cardiovascular disease. Environmental Research 2017; 152: 185 doi: 10.1016/j.envres.2016.10.019
|
18 |
Hye Jin Yoo, Minjoo Kim, Sang-Hyun Lee, Jong Ho Lee. Elevated Lipoprotein-Associated Phospholipase A2 Independently Affects Age-Related Increases in Systolic Blood Pressure: A Nested Case-Control Study in a Prospective Korean Cohort. International Journal of Hypertension 2020; 2020: 1 doi: 10.1155/2020/5693271
|
19 |
Mabel Toribio, Kathleen V. Fitch, Laura Sanchez, Tricia H. Burdo, Kenneth C. Williams, Craig A. Sponseller, Mary McCurdy Pate, Judith A. Aberg, Markella V. Zanni, Steven K. Grinspoon. Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV. AIDS 2017; 31(6): 797 doi: 10.1097/QAD.0000000000001427
|
20 |
Jonathan Sheinberg, Pranav Rajaram, Joshua Callaway. Liposomal-Associated Phospholipase A2 Is More Effective in Predicting Cardiac Risk in Law Enforcement Than Framingham Risk Score and Coronary Artery Calcium Score Calculation. Journal of Occupational & Environmental Medicine 2024; 66(3): 263 doi: 10.1097/JOM.0000000000003035
|
21 |
Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention. IJC Heart & Vasculature 2020; 28: 100541 doi: 10.1016/j.ijcha.2020.100541
|
22 |
Robert M. Schilke, Cassidy M. R. Blackburn, Temitayo T. Bamgbose, Matthew D. Woolard. Interface of Phospholipase Activity, Immune Cell Function, and Atherosclerosis. Biomolecules 2020; 10(10): 1449 doi: 10.3390/biom10101449
|
23 |
Peng Ji, Qixing Kou, Jiewen Zhang. Study on Relationship Between Carotid Intima-Media Thickness and Inflammatory Factors in Obstructive Sleep Apnea. Nature and Science of Sleep 2022; : 2179 doi: 10.2147/NSS.S389253
|
24 |
Da Young Lee. Emerging Circulating Biomarkers for Enhanced Cardiovascular Risk Prediction. Journal of Lipid and Atherosclerosis 2024; 13(3): 262 doi: 10.12997/jla.2024.13.3.262
|
25 |
Lin Lin, Jie Teng, Yiqin Shi, Qiwen Xie, Bo Shen, Fangfang Xiang, Xuesen Cao, Xiaoqiang Ding, Xialian Xu, Zhen Zhang. Lipoprotein-associated phospholipase A2 predicts cardiovascular death in patients on maintenance hemodialysis: a 7-year prospective cohort study. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-023-01991-0
|
26 |
Stefan Stender, Anne Tybjærg-Hansen. Using human genetics to predict the effects and side-effects of drugs. Current Opinion in Lipidology 2016; 27(2): 105 doi: 10.1097/MOL.0000000000000280
|
27 |
Yang Wang, Shiyu Hu, Lijie Ren, Zhihao Lei, Tao Lan, Jingjing Cai, Chao Li. Lp-PLA2 as a risk factor of early neurological deterioration in acute ischemic stroke with TOAST type of large arterial atherosclerosis. Neurological Research 2019; 41(1): 1 doi: 10.1080/01616412.2018.1493850
|
28 |
Jiahuan Chen, Huanyu Zhang, Linquan Li, Xinwei Zhang, Dazhong Zhao, Lingyu Wang, Jiaqi Wang, Ping Yang, Huan Sun, Kun Liu, Weiwei Chen, Lin Li, Feng Lin, Zhanjun Li, Y. Eugene Chen, Jifeng Zhang, Daxin Pang, Hongsheng Ouyang, Yuquan He, Jianglin Fan, Xiaochun Tang.
Lp-PLA
2
(Lipoprotein-Associated Phospholipase A
2
) Deficiency Lowers Cholesterol Levels and Protects Against Atherosclerosis in Rabbits
. Arteriosclerosis, Thrombosis, and Vascular Biology 2023; 43(1) doi: 10.1161/ATVBAHA.122.317898
|
29 |
Renato Quispe, Thomas Das, Erin D. Michos. Precision Medicine in Cardiovascular Disease Prevention. 2021; : 31 doi: 10.1007/978-3-030-75055-8_2
|
30 |
Mariana Vieira de Mello Barros Pimentel, Adriana Bertolami, Lígia Prestes Fernandes, Lúcia Pereira Barroso, Inar Alves Castro. Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease?. Biomedicine & Pharmacotherapy 2023; 160: 114345 doi: 10.1016/j.biopha.2023.114345
|
31 |
Hai-Bing Ju, Fu-Xian Zhang, Shuang Wang, Jie Song, Tao Cui, Li-Feng Li, Hai-Yan Zhang. Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients. Medicine 2017; 96(31): e7671 doi: 10.1097/MD.0000000000007671
|
32 |
Shaoqiu Zhuo, Robert L. Wolfert, Chong Yuan. Biochemical differences in the mass and activity tests of lipoprotein-associated phospholipase A 2 explain the discordance in results between the two assay methods. Clinical Biochemistry 2017; 50(18): 1209 doi: 10.1016/j.clinbiochem.2017.08.019
|
33 |
Sherin Saheera. Multifaceted role of cardiovascular biomarkers. Indian Heart Journal 2023; 75(2): 91 doi: 10.1016/j.ihj.2023.01.011
|
34 |
Handrean Soran, Yifen Liu, Safwaan Adam, Tarza Siahmansur, Jan H. Ho, Jonathan D. Schofield, See Kwok, Matthew Gittins, Michael France, Naveed Younis, J.Martin Gibson, Paul N. Durrington, Martin K. Rutter. A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trial. Journal of Clinical Lipidology 2018; 12(1): 44 doi: 10.1016/j.jacl.2017.10.011
|
35 |
Guohua Sheng, Juan Zhou, Chi Zhang, Caijuan Wu, Kairong Huang, Xiaotong Qin, Jie Wu. Relationship between Lp-PLA2 and in-stent restenosis after coronary stenting: a 3-year follow-up study. Scottish Medical Journal 2021; 66(4): 178 doi: 10.1177/00369330211034809
|
36 |
Martina Fabris, Adriana Cifù, Cinzia Pistis, Massimo Siega-Ducaton, Desrè Ethel Fontana, Roberta Giacomello, Elio Tonutti, Francesco Curcio. Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies. Autoimmunity Highlights 2017; 8(1) doi: 10.1007/s13317-017-0092-7
|
37 |
Serena Cecchetti, Francesca Spadaro, Sandra Gessani, Franca Podo, Laura Fantuzzi. Phospholipases: at the crossroads of the immune system and the pathogenesis of HIV-1 infection. Journal of Leukocyte Biology 2017; 101(1): 53 doi: 10.1189/jlb.3RU0316-148RR
|
38 |
Hema Kothari, Anh T. Nguyen, Xiaohong Yang, Yohei Hisada, Sotirios Tsimikas, Nigel Mackman, Angela Taylor, Coleen A. McNamara. Association of D-dimer with Plaque Characteristics and Plasma Biomarkers of Oxidation-Specific Epitopes in Stable Subjects with Coronary Artery Disease. Journal of Cardiovascular Translational Research 2018; 11(3): 221 doi: 10.1007/s12265-018-9790-4
|
39 |
Jinyang Lu, Dandan Niu, Di Zheng, Quan Zhang, Wenhua Li. Predictive value of combining the level of lipoprotein-associated phospholipase A2 and antithrombin III for acute coronary syndrome risk. Biomedical Reports 2018; doi: 10.3892/br.2018.1162
|
40 |
Liyuan Han, Chongke Zhong, Xiaoqing Bu, Tan Xu, Aili Wang, Yanbo Peng, Tian Xu, Jinchao Wang, Hao Peng, Qunwei Li, Zhong Ju, Deqing Geng, Yonghong Zhang, Jiang He. Prognostic value of lipoprotein-associated phospholipase A2 mass for all-cause mortality and vascular events within one year after acute ischemic stroke. Atherosclerosis 2017; 266: 1 doi: 10.1016/j.atherosclerosis.2017.09.013
|
41 |
Corina Bello, Julian Rössler, Peter Shehata, Nathaniel R. Smilowitz, Kurt Ruetzler. Perioperative strategies to reduce risk of myocardial injury after non-cardiac surgery (MINS): A narrative review. Journal of Clinical Anesthesia 2023; 87: 111106 doi: 10.1016/j.jclinane.2023.111106
|
42 |
Yujing Huang, Liping Wang, Ying Mao, Guangxian Nan. Long Noncoding RNA-H19 Contributes to Atherosclerosis and Induces Ischemic Stroke via the Upregulation of Acid Phosphatase 5. Frontiers in Neurology 2019; 10 doi: 10.3389/fneur.2019.00032
|
43 |
Abdulhamied Alfaddagh, Seth S. Martin, Thorsten M. Leucker, Erin D. Michos, Michael J. Blaha, Charles J. Lowenstein, Steven R. Jones, Peter P. Toth. Inflammation and cardiovascular disease: From mechanisms to therapeutics. American Journal of Preventive Cardiology 2020; 4: 100130 doi: 10.1016/j.ajpc.2020.100130
|
44 |
Zhenli Cheng, Haobo Weng, Jing Zhang, Qijian Yi. The Relationship Between Lipoprotein-Associated Phospholipase-A2 and Coronary Artery Aneurysm in Children With Kawasaki Disease. Frontiers in Pediatrics 2022; 10 doi: 10.3389/fped.2022.854079
|
45 |
Andrew Gessouroun, Brigid C. Flynn. Increasing the Perioperative Specialists Role: Comment on the 2021 American Heart Association Scientific Statement on Myocardial Injury After Noncardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia 2022; 36(4): 932 doi: 10.1053/j.jvca.2021.10.042
|
46 |
Linlin Wu, Peng Shao, Zhanyi Gao, Shan Zhang, Jiahui Ma, Jie Bai, Yuejuan Wei. Homocysteine and Lp-PLA2 levels: Diagnostic value in coronary heart disease. Medicine 2023; 102(46): e35982 doi: 10.1097/MD.0000000000035982
|
47 |
Wei-Sheng Chung, Cheng-Li Lin. Incidence and risk of acute coronary syndrome in patients with acute pancreatitis: A nationwide cohort study. Pancreatology 2017; 17(5): 675 doi: 10.1016/j.pan.2017.07.189
|
48 |
Anwar Santoso, Teuku Heriansyah, Mohammad S. Rohman. Phospholipase A2 is an Inflammatory Predictor in Cardiovascular Diseases: Is there any Spacious Room to Prove the Causation?. Current Cardiology Reviews 2020; 16(1): 3 doi: 10.2174/1573403X15666190531111932
|